CT26.WT/Cre cells are derived from the mouse colon carcinoma CT26.WT cell line by stably integration of a constitutive Cre recombinase stably expression construct. The CT26.WT cell line has been widely used in cancer research and drug development. CT26.WT/Cre cells stably express a nuclear localized Cre recombinase.